Company intelligence / Profile preview

Tedor Pharma

Cumberland, Rhode Island, United Statestedorpharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Tedor Pharma provides contract development and manufacturing services for solid dose pharmaceuticals, including controlled substances. The company offers formulation development, analytical services, clinical trial support, and GMP commercial manufacturing. It does not have its own clinical pipeline but supports clients from preclinical through commercialization.

No proprietary clinical results or programs reported.

Excellent regulatory track record with FDA registration and DEA licensure for Schedules II–V.

Modalities: Small moleculessolid oral dosage formscontrolled substances (Schedules II–V)
Industry: Contract Manufacturing Organization

Partnerships

Not specifically listed; partners with various pharmaceutical/life science companies as clients.

Beyond the preview

Go deeper on Tedor Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tedor Pharma.

Explore the full profile